Safety and Efficacy Study of Lithium in Bipolar Disorder
NCT00422331 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 206
Last updated 2007-08-14
Summary
The purpose of this study is to determine whether Lithium is safe and effective in the treatment of Bipolar I Disorder subjects with symptoms of acute mania.
Conditions
Interventions
- DRUG
-
Lithium Carbonate Capsule
Sponsors & Collaborators
-
JDS Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
NCT00099229 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium
NCT01919892 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Combined Treatment for Young Bipolar I Disorder
NCT00976794 ·Status: COMPLETED ·Phase: PHASE4
-
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918 ·Status: ACTIVE_NOT_RECRUITING
-
Lithium for the Treatment of Pediatric Mania
NCT00442039 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Ketamine and Lithium Therapy in Bipolar Depression
NCT01768767 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China
NCT06424613 ·Status: RECRUITING
-
Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
NCT00563992 ·Status: COMPLETED ·Phase: PHASE1
-
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
NCT07288320 ·Status: RECRUITING ·Phase: PHASE2
-
Lithium for Suicidal Behavior in Mood Disorders
NCT01928446 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder
NCT00238485 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance Therapies in Bipolar Disorders
NCT00000369 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
NCT00224510 ·Status: COMPLETED ·Phase: PHASE3
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
NCT00596622 ·Status: COMPLETED ·Phase: PHASE4
-
VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00264173 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
NCT00107926 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness Study for Bipolar Disorder
NCT01331304 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder
NCT00226135 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2979165 in Healthy Subjects
NCT01383967 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Mania Symptoms With Drug Therapy
NCT00183443 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
NCT01191918 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
NCT00106405 ·Status: COMPLETED ·Phase: PHASE2
-
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
NCT00221429 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
NCT04819776 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.
NCT00228059 ·Status: COMPLETED ·Phase: PHASE3